What’s Hot and What’s Not in IO 2021? Oncology venture funding, IPOs and partnerships have been exceptionally high in deal volume and values. Cancer continues to be the leading therapeutic area in the number and size of early deals, and the oncology pipeline continues to be a rich source of both follow-on agents as well as first-in-class programs. BioPharma Life Sciences Webinars
Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public? 2020 was an unprecedented year for Special Purpose Acquisition Corps (SPACs), an alternative public offering (APO) financing vehicle for listing on a public stock exchange. Best Practices & Trends Finance Life Sciences Mergers & Acquisitions Webinars
Cybersecurity Best Practices for 2021 If cybersecurity is not on the top of your company's list of initiatives for 2021, then it should be, and even if it is, you may not be doing enough. Best Practices & Trends Security Webinars
Practical Application of Artificial Intelligence in Drug Discovery and Development In this whitepaper, learn what is artificial intelligence and how is it being applied to drug discovery, and much more. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
The Seven Habits of Highly Effective Data Rooms In this whitepaper, you will learn the seven "habits" of highly effective data rooms to ensure your selection facilitates the due diligence process rather than impede it. Best Practices & Trends Energy Finance Legal Life Sciences Other Industries Real Estate Virtual Data Room Whitepapers
Essential Steps to Successful Biopharma Partnering This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering. BioPharma Licensing & Partnering Life Sciences Whitepapers
Valuation of Your Early Drug Candidate In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner. Life Sciences Series Valuation Whitepapers
Preparing Your Company for the M&A Process When it’s time to exit your business, being prepared and having a well-planned exit strategy can be the difference between a good transaction and a great one. Best Practices & Trends Finance Mergers & Acquisitions Whitepapers
The Art & Science of High M&A Valuation This whitepaper shares the core aspects of the Technology Buyer's key valuation and diligence checklist. Best Practices & Trends Finance Mergers & Acquisitions Valuation Whitepapers
Best Practices for Fundraising and M&A Due Diligence This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more. Due Diligence Finance Fundraising Mergers & Acquisitions Whitepapers
Successful Biotech Licensing Negotiations In this whitepaper, Linda Pullan provides licensing negotiations insights from a biotech business development perspective. BioPharma Life Sciences Other Topics Whitepapers
A Medical Device Manufacturer's Guide to Selecting Suppliers This white paper covers when to consider using suppliers, key differences between standard / OTS and custom part suppliers, tools and methods for managing suppliers, and when and how to transition between suppliers and internal resources. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers